Dernières nouvelles
Information non disponible
Telephone consultations in urology: Who, when, where, and why?
Article de revueCan Urol Assoc J, 11 (12), 2017.
Dimercaptosuccinic acid scintigraphy vs. ultrasound for renal parenchymal defects in children
Article de revueCan Urol Assoc J, 11 (8), 2017.
Vesicoureteral reflux: From prophylaxis to surgery
Article de revueCan Urol Assoc J, 11 (1-2Suppl1), 2017.
Dual Therapy for Refractory Overactive Bladder in Children: A Prospective Open-Label Study
Article de revueJ Urol, 197 (4), 2017.
Polyacrylamide Hydrogel as a Bulking Agent for the Endoscopic Treatment of Vesicoureteral Reflux: Long-Term Results and Safety
Article de revueJ Urol, 197 (3 Pt 2), 2017.
Prospective Pilot Study of Mirabegron in Pediatric Patients with Overactive Bladder
Article de revueEur Urol, 70 (1), 2016.
Endoscopic treatment and vesicoureteral reflux
Chapitre de livreNewport LP (Ed.): Vesicoureteral reflux and pyelonephritis : risk factors, prevalence and treatment approaches, p. 55-84, Hauppauge, NY, Nova Science Publishers, 2015, ISBN: 9781634634977.
Vesicoureteral reflux: diagnosis and treatment
Chapitre de livreNewport LP (Ed.): Vesicoureteral reflux and pyelonephritis : risk factors, prevalence and treatment approaches, p. 19-54, Hauppauge, NY, Nova Science Publishers, 2015, ISBN: 9781634634977.
Efficacy of dextranomer hyaluronic acid and polyacrylamide hydrogel in endoscopic treatment of vesicoureteral reflux: A comparative study
Article de revueCan Urol Assoc J, 9 (5-6), 2015.
Double anticholinergic therapy for refractory neurogenic and nonneurogenic detrusor overactivity in children: Long-term results of a prospective open-label study
Article de revueCan Urol Assoc J, 8 (5-6), 2014.